**IMPORTANT**

The information contained in the Organizational Database (ODB) is provided
for informational purposes only. There is no implied endorsement by NORD. NORD
does not promote or endorse participation in any specific organization. The
information is subject to change without notice. Every effort is made to ensure
that the details for each entry are as current as possible.

Myositis Association

a/k/a: TMA

Address

1737 King Street
Suite 600 Alexandria, VA 22314 USA

Phone

703-299-4850

Fax

703-535-6752

800 Number

800-821-7356

TDD

--

Email Address

tma@myositis.org

Website

The Myositis Association (TMA) is an international non-profit organization dedicated to helping people with inflammatory myopathies through a variety of programs. Inflammatory myopathies are a group of muscle disorders characterized by inflammation and degeneration of the skeletal muscles. These disorders include dermatomyositis, polymyositis, inclusion body myositis and juvenile forms of myositis. Established in 1993, the association provides continuing education to physicians through symposia, maintains a database for collaboration with medical scientists, and funds research into the causes, treatment and eventual cure of inflammatory myopathies. TMA provides extensive services for myositis patients and their families. TMA organizes national conferences featuring world-renowned speakers, and produces numerous newsletter, which provide education, and articles that enhance the lives of individuals with inflammatory myopathies. The association also provides area support groups and an active online community for patient and family support.

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents
thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be
copied in any way, including but not limited to the following: electronically downloading, storing
in a retrieval system, or redistributing for any commercial purposes without the express written
permission of NORD. Permission is hereby granted to print one hard copy of the information on
an individual disease for your personal use, provided that such content is in no way modified,
and that credit for the source (NORD) and NORD’s copyright notice are included on the printed
copy. Any other electronic reproduction or other printed versions are strictly prohibited.